AVBP Earnings & Financial Statements
ArriVent BioPharma, Inc. Common Stock
$16.20
+$0.11(+0.68%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$798.79M
Volume
1.59M
52W Range
$11.36 - $35.83
Target Price
$23.40
AVBP earnings and financial statements: ArriVent BioPharma, Inc. Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.
AVBP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2022 |
|---|---|---|---|
| Operating income | -$177.53M | -$94.31M | -$36.91M |
| EBITDA | -$169.33M | -$80.49M | - |
| Net income | -$166.31M | -$80.49M | -$36.91M |
| EPS (diluted) | $-4.32 | $-2.56 | $-0.03 |
| Fiscal year | 2025 | 2024 | 2022 |
|---|---|---|---|
| Total assets | $333.17M | $274.94M | $182.83M |
| Total liabilities | $25.95M | $17.29M | $8.37M |
| Shareholders’ equity | $307.22M | $257.65M | $174.46M |
| Cash and equivalents | $45.54M | $74.29M | $163.37M |
| Long-term debt | - | $14.0K | $11.0K |
| Fiscal year | 2025 | 2024 | 2022 |
|---|---|---|---|
| Operating cash flow | -$160.59M | -$70.21M | -$43.63M |
| Free cash flow | -$160.59M | -$70.21M | -$43.63M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVBP | $16.20 | +0.7% | 1.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ArriVent BioPharma, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW